Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.
Ku Z, Xie X, Lin J, Gao P, Wu B, El Sahili A, Su H, Liu Y, Ye X, Tan EY, Li X, Fan X, Goh BC, Xiong W, Boyd H, Muruato AE, Deng H, Xia H, Zou J, Kalveram BK, Menachery VD, Zhang N, Lescar J, Shi PY, An Z.
Ku Z, et al. Among authors: goh bc.
Nat Commun. 2022 Sep 22;13(1):5552. doi: 10.1038/s41467-022-33284-y.
Nat Commun. 2022.
PMID: 36138032
Free PMC article.